| Literature DB >> 25649941 |
Özge Turna Yilmaz1, T Seval Fatma Toydemir, İsmail Kirşan, Banu Dokuzeylul, Zeynep Gunay, Esra Karacam.
Abstract
The analgesic effect of wound infiltration with bupivacaine was evaluated in cats undergoing bilateral mastectomy. Twenty-one female cats with mammary gland tumors were anesthetized with propofol and oxygen-isoflurane anesthesia following premedication with atropine. In the trial group (Group I; n=11), 30 ml of saline containing 2 mg/kg of bupivacaine was infiltrated topically into the surgical wound right after removal of the mammary glands, whereas only saline solution was infiltrated in the control group (Group II; n=10). At the same time, carprofen (4 mg/kg) was also administered subcutaneously in both groups. Behavioral signs of pain were monitored during the recovery period after general anesthesia. In order to examine the behavioral changes associated with acute pain, a questionnaire was prepared and given to the owners to be completed 4 hr and then 10 hr after the operation. According to the owners' anwers to the questionnaire, a pain score was specified using a "numerical rating scale" for each cat. Although some cats showed mild to moderate pain, the pain score recorded at 4 hr after the operation was significantly lower in Group I (P<0.001). No significant difference was found at 10 hr after the operation between the groups. The incidence of vocalization, aggression and convulsion within 2 hr after the operation was also lower in Group I. In conclusion, wound infiltration with bupivacaine before incisional closure provided reliable analgesia at least 4 hr after bilateral radical mastectomy in cats.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25649941 PMCID: PMC4300374 DOI: 10.1292/jvms.14-0112
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Fig. 1.Irrigation solution was administered to the surgical area through an impregnated gauze after the removal of the mammary glands.
Characteristic features, reproductive histories, histopathological results and outcomes of the patients
| No. | Group | Age | Breed | Neutered +/− | Mammary glands with a mass | TNM | Histopathology | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 15 | Persian | + | Caudo-thoracal | T2N0M0 | Tubular carcinoma | Still alive at 12 months |
| Abdominal | ||||||||
| 2 | 1 | 15 | Mix | + | Cranio-thoracal | T3N1M0 | Solid adenocarcinoma | Died within 5 months |
| 3 | 1 | 10 | Mix | + | Cranio-thoracal | T3N1M0 | Solid adenocarcinoma | Died within 6 months |
| 4 | 1 | 15 | Siamese | + | Abdominal | T2N1M0 | Tubular adenocarcinoma | Died within 2 months (renal insufficiency) |
| Inguinal | ||||||||
| 5 | 1 | 8 | Turkish Angora Cat | + | All glands | T3N1M0 | Solid adenocarcinoma | Died within 2 months |
| 6 | 1 | 10 | Persian | + | Abdominal | T2N0M0 | Solid adenocarcinoma | Died within 1 year |
| Inguinal | ||||||||
| 7 | 1 | 11 | Mix | + | Abdominal | T2N1M0 | Tubular adenocarcinoma | Died within 6 months (renal insufficiency) |
| Inguinal | ||||||||
| 8 | 1 | 13 | Mix | – | Inguinal | T1N0M0 | Solid adenocarcinoma | Still alive at 12 months |
| 9 | 1 | 14 | Turkish Angora Cat | + | Caudo-thoracal | T2N0M0 | Tubular adenocarcinoma | Still alive at 12 months |
| 10 | 1 | 12 | Mix | – | All glands | T3N1M0 | Tubular adenocarcinoma | Died within 2 months |
| 11 | 1 | 9 | Mix | – | Inguinal | T2N0M0 | Solid adenocarcinoma | Still alive at 12 months |
| 12 | 2 | 15 | Mix | – | All glands | T3N0M0 | Tubulopapillary adenocarcinoma | Died within 11 months |
| 13 | 2 | 16 | Mix | + | All glands | T3N1M0 | Tubular adenocarcinoma | Died within 3 months |
| 14 | 2 | 12 | Mix | – | All glands | T3N1M0 | Tubulopapillary adenocarcinoma | Died within 5 months |
| 15 | 2 | 12 | Siamese | – | Thoracal glands | T1N0M0 | Intraductal adenocarcinoma | Died within 1 year |
| 16 | 2 | 11 | Mix | – | All glands | T3N1M0 | Tubulopapillary adenocarcinoma | Died within 1 month (renal insufficiency) |
| 17 | 2 | 8 | Persian | + | All glands | T2N0M0 | Cystic adenomatous hyperplasia | Still alive at 12 months |
| 18 | 2 | 10 | Mix | ORS* | Inguinal | T3N1M0 | Tubular adenocarcinoma | Died within 5 moths |
| 19 | 2 | 12 | Persian | + | All glands | T2N1M0 | Solid adenocarcinoma | Died within 8 months |
| 20 | 2 | Unknown | Mix | + | Caudo-thoracal | T2N0M0 | Tubular adenocarcinoma | Died within 1 year |
| Abdominal | ||||||||
| 21 | 2 | 14 | Mix | – | Inguinal | T3N1M0 | Tubular adenocarcinoma | Died within 3 months |
*Ovarian remnant syndrome.
Fig. 2.Changes in behavioral signs of pain (vocalization, aggression and convulsion), respiratory rate, heart rate, and systolic and diastolic blood pressure. Significant difference between the groups: *P<0.05, **P<0.01, ***P<0.001.
Fig. 3.Mean pain scores for the groups at 4 and 10 hr after the operation. Significant difference between the groups: *P<0.001.